The International Market Analysis Research and Consulting Group (IMARC Group) has been keeping the top position in terms of provision consultancy services on management strategy and market for above 5 years.
IMARC Group serves customers from diverse industry areas in various regions of the globe by identifying their premium-value biz opps, dealing with their most burning issues, and converting their businesses. The company bears its clients a hand in improving decision-making and strategy-planning processes as well as in moving their business to a higher level.
The reports published by IMARC offer precise information on a slew of industries such as pharmaceutical, high-technology, advanced materials, food and beverage, biotechnology, nanotechnology, tourism and travel and a far more. The reports include detailed market analyses, overviews and forecasts, reviews of the economic and technological developments, profiles of the dominant companies, market/product assessments, etc. IMARC’s research approach unites deep insight into the market dynamics together with strong cooperation with each level of the client organization.
Publications found:
9,055
Sort by:
Chronic Hepatitis B Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034
US$ 6,499.00
The 7 major chronic hepatitis B markets reached a value of US$ 2,709.4 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 3,379.3 Million by 2034, exhibiting a growth rate (CAG...
May 2024
140 pages
Chronic Obstructive Pulmonary Disease Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034
US$ 6,499.00
The 7 major chronic obstructive pulmonary disease markets reached a value of US$ 13,464.0 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 18,551.6 Million by 2034, exhibitin...
May 2024
133 pages
Cluster Headache Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034
US$ 6,499.00
The 7 major cluster headache markets reached a value of US$ 812.8 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 1,124.6 Million by 2034, exhibiting a growth rate (CAGR) of...
May 2024
131 pages
Common Warts Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034
US$ 6,499.00
The 7 major common warts markets reached a value of US$ 761.4 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 1,056.6 Million by 2034, exhibiting a growth rate (CAGR) of 3.0...
May 2024
137 pages
Concussions Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034
US$ 6,499.00
The 7 major concussions markets reached a value of US$ 792.2 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 1,069.3 Million by 2034, exhibiting a growth rate (CAGR) of 2.76...
May 2024
128 pages
Congenital Ichthyosis Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034
US$ 6,499.00
The Congenital Ichthyosis market reached a value of US$ 5.0 Million across the top 7 markets (US, EU4, UK, and Japan) in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 8.0 Million by...
May 2024
128 pages
Crohn's Disease Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034
US$ 6,499.00
The 7 major Crohn's disease markets reached a value of US$ 8,319.5 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 11,796.7 Million by 2034, exhibiting a growth rate (CAGR)...
May 2024
139 pages
Cystic Fibrosis Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity and Forecast 2024-2034
US$ 6,499.00
The 7 major cystic fibrosis markets reached a value of US$ 10,158.0 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 62,492.2 Million by 2034, exhibiting a growth rate (CAGR)...
May 2024
137 pages
